ClinConnect ClinConnect Logo
Search / Trial NCT03859258

Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar

Launched by CAIRO UNIVERSITY · Feb 27, 2019

Trial Information

Current as of June 20, 2025

Completed

Keywords

ClinConnect Summary

Cesarean delivery is amongst the most widely recognized operations performed on women and its rate continue expanding. The rates of cesarean section (CS) in the United States in 1996 and 2009 were 20.7% and 32.3% respectively, witnessing an expansion of more than half. In China, 50% of deliveries in 2010 were through CS. In the Netherlands, the cesarean delivery rate jumped from 7.4 to 15.8% between 1990 and 2008, whereas in the United Kingdom, the CS rate increased from 12 to 29% throughout the same time period. In Brazil, the CS rate jumped from 15% in 1970 to even 80% in 2004.

The expan...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Cases are delivered by Lower segment cesarean section
  • 2. Controls are delivered vaginally
  • 3. Singleton fetus
  • 4. Living fetus
  • 5. Term pregnancy
  • Exclusion Criteria:
  • 1. Placenta praevia
  • 2. Congenital fetal anomalies
  • 3. Severe oligohydramnios(MVP \<2cm)
  • 4. Rupture of membranes more than 18 hours
  • 5. Puerperal pyrexia or sepsis
  • 6. Bladder injury
  • 7. Blood transfusion

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Mona M Aboulghar, M.D.

Principal Investigator

Cairo University

Hassan M Gaafar, M.D.

Principal Investigator

Cairo University

Hisham M Haggag, M.D.

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials